Adcock Ingram Holdings | AIP

Stock Price
7,187.00
Daily Change
-13.00 -0.18%
Monthly
4.16%
Yearly
10.77%
Q3 Forecast
7,142.44

Peers Price Chg Day Year Date
Avita Medical 1.34 0.01 0.75% -48.46% Sep/05
Adcock Ingram Holdings 7,187.00 -13.00 -0.18% 10.77% Sep/05
Aspen Pharmacare 10,393.00 113.00 1.10% -47.85% Sep/05
Tectonic Therapeutic 16.80 -0.47 -2.72% -8.50% Sep/05
Ionis Pharmaceuticals 61.23 1.88 3.17% 30.58% Sep/05
IQVIA Holdings 187.68 3.60 1.96% -22.83% Sep/05
Life Healthcare 1,312.00 4.00 0.31% -8.70% Sep/05
Dianthus Therapeutics 26.50 1.84 7.46% -0.45% Sep/05
Moderna 25.14 0.86 3.54% -65.54% Sep/05
Netcare 1,389.00 19.00 1.39% 3.50% Sep/05
Organon & Co 10.38 0.70 7.23% -49.40% Sep/05
Revvity 86.64 0.94 1.10% -24.90% Sep/05
Viatris 10.50 0.17 1.65% -6.87% Sep/05
Xeris Pharmaceuticals 7.85 -0.04 -0.51% 212.75% Sep/05
Alaunos Therapeutics 2.16 0 0% -10.74% Sep/05


Adcock Ingram Holdings Ltd traded at 7,187.00 this Friday September 5th, decreasing 13.00 or 0.18 percent since the previous trading session. Looking back, over the last four weeks, Adcock Ingram Holdings lost 4.16 percent. Over the last 12 months, its price rose by 10.77 percent. Looking ahead, we forecast Adcock Ingram Holdings Ltd to be priced at 7,142.44 by the end of this quarter and at 7,010.41 in one year, according to Trading Economics global macro models projections and analysts expectations.

Adcock Ingram Holdings Limited is a South Africa-based healthcare company. The Company’s segments include Consumer, Over the Counter (OTC), Prescription, Hospital, and Other. The Consumer segment is engaged mainly in the fast-moving consumer goods (FMCG) space. Its OTC segment focuses on brands sold predominantly in pharmacies. Its Prescription segment markets products prescribed by medical practitioners, and specialized instruments and surgical products. Its Hospital segment supplies hospital and critical care products, including intravenous solutions, blood collection products and renal dialysis systems. Its Other segment include shared services and other support services, including regulatory services in India, as well as the investment in the joint venture and cash and bank overdraft balances which are managed on a central basis in Southern Africa.